Comparative efficacy of DRAXXIN or Micotil for the control of respiratory disease in cattle at high risk of developing undifferentiated bovine respiratory disease

Introduction DRAXXIN contains the active ingredient tulathromycin, the first of a new subclass of macrolide, the triamilides, discovered and developed by Pfizer Animal Health. DRAXXIN is a highly effective, single-dose antimicrobial medication indicated for treatment of BRD, and control of respiratory disease in cattle at high risk of developing BRD, caused by M haemolytica, P multocida and H somni (Haemophilus somnus).